Using the CML drug Tasigna® may lead to Limb Amputation, Serious Blood Clots, Heart Attack, Stroke or Death.
The chronic myeloid leukemia (CML) drug Tasigna® has been linked to the rapid onset of atherosclerosis and coronary artery disease (sometimes referred to as hardening of the arteries). These conditions can lead to amputations, cardiovascular problems and sometimes death. If you suffered serious side effects or a loved one died after taking Tasigna® for CML, call the Gold Shield Group at 800-972-5291 for a free/no obligation case review.
How Does Tasigna® Work?
Tasigna® is a type of drug known as a protein tyrosine kinase inhibitor. It was designed to only attack cells that carry the tyrosine kinase protein (cancer cells) while leaving healthy cells unharmed. It does this by blocking the growth of specific proteins necessary to grow cancer cells. Unfortunately, Tasigna® has also been associated with the onset of atherosclerosis, a condition where plaque builds up inside the arteries.
Atherosclerosis and Other Side Effects
Atherosclerosis often leads to poor circulation due to the buildup of plaque in the arteries. In turn, poor circulation often leads to serious side effects including:
• Limb Amputation
• Serious Blood Clots
• Carotid Artery Disease
• Coronary Artery Disease
• Peripheral Artery Disease
• Hardening or Narrowing of Arteries
• Death (Due to one of the above complications)
If you suffered serious side effects or a loved one died after taking Tasigna®, you may qualify for money damages. Call the Gold Shield Group at 800-972-5291.